Search
NEXEL、日本DNPとヒト由来幹細胞心筋細胞の培養技術提携
NEXEL begins listing on KOSDAQ... Submission of request for preliminary evaluation
NEXEL Passes Technology Evaluation
BioHealth R&D Best Companies Awards
Nexel Announces Results of Cardiac Safety Pharmacology Research at the World Society of Safety Pharmacology
NEXEL Signs 'hiPSC Business Partnership' Agreement With Japan's CMIC Holdings
NEXEL, Sales of 1.73 billion won in the first half thanks to CDMO sales in the US
NEXEL, attends Chinese and Japanese conferences "Global publicity of hiPSC excellence"
NEXEL, Accelerate business cooperation with CMIC, Japan's largest CRO company
NEXEL, accelerating iPSC commercialization...Goal for KOSDAQ listing next year
Please enter your password first.
Password
CloseConfirm